The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase

Virology

Volumn 361, Issue 1, 2007, Pages 149-160

  Li, Kejun ^a   Zhang, Shujing ^a   Kronqvist, Malin ^a   Ekström, Maria ^a   Wallin, Michael ^a   Garoff, Henrik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CXXC motif; Disulphide isomerization; Env activation; Fusion from without; Membrane fusion; Moloney murine leukemia virus; Receptor binding; Thiol ionization

Indexed keywords

ISOMERASE; MEMBRANE FUSION PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVITY; IMMUNOPRECIPITATION; IN VITRO STUDY; IONIZATION; ISOMERIZATION; MEMBRANE FUSION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELL MEMBRANE; HISTIDINE; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; MOLONEY MURINE LEUKEMIA VIRUS; PROTEIN DISULFIDE-ISOMERASE; PROTEIN SUBUNITS; RECEPTORS, VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

MOLONEY MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS;

EID: 34047261817     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.11.013     Document Type: Article

References (40)

1. Bae Y., Kingsman S.M., and Kingsman A.J. Functional dissection of the Moloney murine leukemia virus envelope protein gp70, PG-2092-9. J. Virol. 71 3 (1997) 2092-2099
2. Barnett A.L., and Cunningham J.M. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion, PG. J. Virol. 75 19 (2001) 9096-9105
3. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 2 (1997) 263-273
4. Davey R.A., Hamson C.A., Healey J.J., and Cunningham J.M. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 71 11 (1997) 8096-8102
5. Fass D., Davey R.A., Hamson C.A., Kim P.S., Cunningham J.M., and Berger J.M. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution, PG-1662-6. Science 277 5332 (1997) 1662-1666
6. Foloppe N., Sagemark J., Nordstrand K., Berndt K.D., and Nilsson L. Structure, dynamics and electrostatics of the active site of glutaredoxin 3 from Escherichia coli: comparison with functionally related proteins. J. Mol. Biol. 310 2 (2001) 449-470
7. Forster F., Medalia O., Zauberman N., Baumeister W., and Fass D. Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography. Proc. Natl. Acad. Sci. U. S. A. 102 13 (2005) 4729-4734 (Electronic publication 2005 Mar 17)
8. Hernandez L.D., Peters R.J., Delos S.E., Young J.A., Agard D.A., and White J.M. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J. Cell Biol. 139 6 (1997) 1455-1464
9. Hunter E. Viral entry and receptors. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbour Laboratory Press 71-119
10. Jiang S., Lin K., Strick N., and Neurath A.R. HIV-1 inhibition by a peptide. Nature 365 6442 (1993) 113
11. Jinno A., Haraguchi Y., Shiraki H., and Hoshino H. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein. J. Virol. 73 11 (1999) 9683-9689
12. Kayman S.C., Park H., Saxon M., and Pinter A. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J. Virol. 73 3 (1999) 1802-1808
13. Kobe B., Center R.J., Kemp B.E., and Poumbourios P. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. PG 4319-24. Proc. Natl. Acad. Sci. U. S. A. 96 8 (1999) 4319-4324
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
15. Lappi A.K., Lensink M.F., Alanen H.I., Salo K.E., Lobell M., Juffer A.H., and Ruddock L.W. A conserved arginine plays a role in the catalytic cycle of the protein disulphide isomerases. J. Mol. Biol. 335 1 (2004) 283-295
16. Lavillette D., Maurice M., Roche C., Russell S.J., Sitbon M., and Cosset F.L. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72 12 (1998) 9955-9965
17. Lavillette D., Ruggieri A., Russell S.J., and Cosset F.L. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments, PG-295-304. J. Virol. 74 1 (2000) 295-304
18. Lavillette D., Boson B., Russell S.J., and Cosset F.L. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein, PG-3685-95. J. Virol. 75 8 (2001) 3685-3695
19. Lavillette D., Ruggieri A., Boson B., Maurice M., and Cosset F.L. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein, PG-9673-85. J. Virol. 76 19 (2002) 9673-9685
20. Li K.J., and Garoff H. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc. Natl. Acad. Sci. U. S. A. 93 21 (1996) 11658-11663
21. Liljestrom P., and Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon, PG-1356-61. Biotechnology (NY) 9 12 (1991) 1356-1361
22. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., and Cohen F.S. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 151 2 (2000) 413-423
23. Moore J.P., McKeating J.A., Weiss R.A., and Sattentau Q.J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250 4984 (1990) 1139-1142
24. Mothes W., Boerger A.L., Narayan S., Cunningham J.M., and Young J.A. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103 4 (2000) 679-689
25. Netter R.C., Amberg S.M., Balliet J.W., Biscone M.J., Vermeulen A., Earp L.J., White J.M., and Bates P. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J. Virol. 78 24 (2004) 13430-13439
26. Opstelten D.J., Wallin M., and Garoff H. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J. Virol. 72 8 (1998) 6537-6545
27. Pinter A., Kopelman R., Li Z., Kayman S.C., and Sanders D.A. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71 10 (1997) 8073-8077
28. Pizzato M., Marlow S.A., Blair E.D., and Takeuchi Y. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J. Virol. 73 10 (1999) 8599-8611
29. Qian Z., and Albritton L.M. An aromatic side chain is required at residue 8 of SU for fusion of ecotropic murine leukemia virus. J. Virol. 78 1 (2004) 508-512
30. Rowe W.P., Pugh W.E., and Hartley J.W. Plaque assay techniques for murine leukemia viruses. Virology 42 4 (1970) 1136-1139
31. Smith J.G., Mothes W., Blacklow S.C., and Cunningham J.M. The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection. J. Virol. 78 3 (2004) 1403-1410
32. Suomalainen M., and Garoff H. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68 8 (1994) 4879-4889
33. Wallin M., Ekstrom M., and Garoff H. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 23 1 (2004) 54-65 (Electronic publication 2003 Dec 11)
34. Wallin M., Ekstrom M., and Garoff H. The fusion-controlling disulfide bond isomerase in retrovirus env is triggered by protein destabilization. J. Virol. 79 3 (2005) 1678-1685
35. Wallin M., Loving R., Ekstrom M., Li K., and Garoff H. Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus. J. Virol. 79 22 (2005) 13856-13864
36. Wallin M., Ekström M., and Garoff H. Receptor triggered but alkylation-arrested Env of murine leukaemia virus reveals the transmembrane subunit in a prehairpin conformation. J. Virol. (2006)
37. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 6631 (1997) 426-430
38. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U. S. A. 91 21 (1994) 9770-9774
39. Zavorotinskaya T., and Albritton L.M. Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein, PG-5034-42. J. Virol. 73 6 (1999) 5034-5042
40. Zavorotinskaya T., Qian Z., Franks J., and Albritton L.M. A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J. Virol. 78 1 (2004) 473-481